can semaglutide cause suicidal thoughts GLP-1 drugs and ideation: Conflicting studies, small risk FDA reports no link between

BioWorld Regulatory Cardiovascular Endocrine/metabolic Obesity Small molecule FDA NDA

We discuss the work-up and management of her condition including a detailed discussion of the differential diagnosis, the underlying features of systemic sclerosis with cardiac involvement as well as cardiac amyloidosis, the role of a shock team in managing cardiogenic shock, and how to identify those with advanced or stage D heart failure

Liu et al

Key findings: Pharmacokinetics were dose proportional Steady-state exposures were maintained with once-weekly dosing Body weight reduction was dose-dependent: up to -8.96 kg in the highest dose group vs placebo at 12 weeks HbA1c reductions of -0.4% to -1.2% across dose groups Safety profile consistent with other incretin drugs (GI adverse events most common) Frequently Asked Questions How long does retatrutide stay in your system

[DOI] [PubMed] [Google Scholar] 494.Dong Y, Ma J, Song Y, et al Secular trends in blood pressure and overweight and obesity in Chinese boys and girls aged 7 to 17 years from 1995 to 2014